Annual report
7317.TEDINET S100TM9Z
Period2023-04-01 → 2024-03-31
Filed2024-06-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 153
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥8.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥7.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥5.6bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.6bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.3bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥612m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.3bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥675m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥409m | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥831m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥381m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.3bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥671m | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥953m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥426m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥165m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥569m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥223m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥953m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥426m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥9.9bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥8.7bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥6.9bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥6.2bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥5.1bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.7bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥5.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥5.2bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.8bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.2bn | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥2.8bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥2.0bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.3bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.3bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.2bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥739m | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥528m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥915m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥140m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥656m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥220m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥616m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥485m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥62m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥42m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥183m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥504m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥43m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥36m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥45.03 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.17 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.85 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.46 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.39 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥44.43 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥20.02 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥7.75 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥26.87 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥244.72 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥178.69 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥153.44 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥134.71 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥111.25 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 52.3% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.2% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.0% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.1% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.6% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 21.3% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.1% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.5% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 23.7% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.8% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,367 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 1,383 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 1,442 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 1,422 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 1,370 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥3.2bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥3.0bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥2.4bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.9bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.3bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥33m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | −¥139m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥347m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥68m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥31m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥673m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥78m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥253m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥261m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥206m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | −¥320m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | −¥4m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥469m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥20m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥4.2bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥4.1bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥3.1bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.1bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.9bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.0bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥3.1bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.2bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.0bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥567m | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥454m | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥913m | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥9.74 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-15.16 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.2 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.67 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1.13 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥9.61 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥22.19 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥2.5 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥56.75 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥47.4 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥63.58 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥63.9 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥31.51 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 28.9% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 24.5% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.8% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.3% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.8% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 18.7% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -27.3% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -0.3% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 49.5% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.7% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 21,223,200 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,281,800 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,275,400 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,598,500 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,250,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 44 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 39 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 39 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 34 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 33 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 56
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2023-04-01 → 2024-03-31 | ¥44m |
| Otherother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥44m |
| Otherother segments | segment assets | at 2024-03-31 | ¥23m |
| Otherother segments | segment profit | 2023-04-01 → 2024-03-31 | ¥19m |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥2m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥4m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥944m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥295m |
| Medical Healthcarereportable segment | capex | 2023-04-01 → 2024-03-31 | ¥297m |
| Medical Healthcarereportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥116m |
| Medical Healthcarereportable segment | employees | at 2024-03-31 | 531 pure |
| Medical Healthcarereportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥5.4bn |
| Medical Healthcarereportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥5.4bn |
| Medical Healthcarereportable segment | segment assets | at 2024-03-31 | ¥3.9bn |
| Medical Healthcarereportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥1.4bn |
| Safety Systemreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥371m |
| Safety Systemreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥155m |
| Safety Systemreportable segment | employees | at 2024-03-31 | 827 pure |
| Safety Systemreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥3.0bn |
| Safety Systemreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥3.0bn |
| Safety Systemreportable segment | segment assets | at 2024-03-31 | ¥5.0bn |
| Safety Systemreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥167m |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥668m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥271m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥8.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥8.4bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥9.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥1.6bn |
| Otherother segments | revenue | 2022-04-01 → 2023-03-31 | ¥24m |
| Otherother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥24m |
| Otherother segments | segment assets | at 2023-03-31 | ¥11m |
| Otherother segments | segment profit | 2022-04-01 → 2023-03-31 | ¥2m |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥533,000 |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥4m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥1.0bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥262m |
| Medical Healthcarereportable segment | capex | 2022-04-01 → 2023-03-31 | ¥711m |
| Medical Healthcarereportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥71m |
| Medical Healthcarereportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥5.1bn |
| Medical Healthcarereportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥5.1bn |
| Medical Healthcarereportable segment | segment assets | at 2023-03-31 | ¥3.4bn |
| Medical Healthcarereportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥1.2bn |
| Safety Systemreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥1.2bn |
| Safety Systemreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥194m |
| Safety Systemreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥2.0bn |
| Safety Systemreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥2.0bn |
| Safety Systemreportable segment | segment assets | at 2023-03-31 | ¥4.2bn |
| Safety Systemreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥349m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥1.9bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥265m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥7.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥7.2bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥7.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥874m |
| Medical Healthcarereportable segment | employees | at 2024-03-31 | 18 pure |
| Safety Systemreportable segment | employees | at 2024-03-31 | 17 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,409
| Item | Context | Value | Unit |
|---|---|---|---|
| Name major shareholders | CurrentYearInstant_No8MajorShareholdersMember | Text · Plus | |
| Address major shareholders | CurrentYearInstant_No8MajorShareholdersMember | Text · Plus | |
| Name major shareholders | CurrentYearInstant_No9MajorShareholdersMember | Original text (Japanese)栗本 英有 | |
| Address major shareholders | CurrentYearInstant_No9MajorShareholdersMember | Original text (Japanese)愛知県一宮市 | |
| Name major shareholders | CurrentYearInstant_No10MajorShareholdersMember | Original text (Japanese)株式会社ＳＢＩ証券 | |
| Address major shareholders | CurrentYearInstant_No10MajorShareholdersMember | Original text (Japanese)東京都港区六本木１丁目６番１号 | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | Original text (Japanese)株主としての権利内容に何ら限定のない当社における標準となる株式であります。なお、１単元の株式数は100株であります。 | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentYearInstant_Row1Member | Original text (Japanese)株式会社松屋アールアンドディ | |
| Address of shareholder treasury shares etc | CurrentYearInstant_Row1Member | Original text (Japanese)福井県大野市鍬掛第20号１番地２ | |
| Classes of shares etc (text) | FilingDateInstant | Text · Plus | |
| Acquisitions by resolution of shareholders meeting (text) | FilingDateInstant | Text · Plus | |
| Acquisitions by resolution of board of directors meeting (text) | FilingDateInstant | Text · Plus | |
| Acquisitions not based on resolution of shareholders meeting or board of directors meeting (text) | FilingDateInstant | Text · Plus | |
| Disposals or holding of acquired treasury shares (text) | FilingDateInstant | Text · Plus | |
| Dividend policy (text) | FilingDateInstant | Text · Plus | |
| Date of resolution dividends of surplus | FilingDateInstant_Row1Member | 2024-06-27 | |
| Resolution dividends of surplus | FilingDateInstant_Row1Member | Original text (Japanese)定時株主総会決議 | |
| Overview of corporate governance (text) | FilingDateInstant | Text · Plus | |
| Corporate governance company with corporate auditors (text) | FilingDateInstant | Text · Plus | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000GotoHidetakaMember | Original text (Japanese)代表取締役社長ＣＥＯ（兼社長執行役員） | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000GotoHidetakaMember | Original text (Japanese)後藤 秀隆 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000GotoHidetakaMember | 1950-01-22 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E35560-000GotoHidetakaMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000GotoHidetakaMember | Original text (Japanese)（注）２ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000NakanoMasashiMember | Original text (Japanese)代表取締役副社長ＣＯＯ（兼副社長執行役員） | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000NakanoMasashiMember | Original text (Japanese)中野 雅史 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000NakanoMasashiMember | 1952-02-10 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E35560-000NakanoMasashiMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000NakanoMasashiMember | Original text (Japanese)（注）２ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000MatsukawaKoichiMember | Original text (Japanese)常務取締役ＣＦＯ（兼常務執行役員）経営管理部長 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000MatsukawaKoichiMember | Original text (Japanese)松川 浩一 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000MatsukawaKoichiMember | 1982-12-14 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E35560-000MatsukawaKoichiMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000MatsukawaKoichiMember | Original text (Japanese)（注) ２ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000SasakiYutakaMember | Original text (Japanese)取締役 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000SasakiYutakaMember | Original text (Japanese)佐々木 豊 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000SasakiYutakaMember | 1956-09-29 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E35560-000SasakiYutakaMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000SasakiYutakaMember | Original text (Japanese)（注) ２ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000HayashiNorieMember | Original text (Japanese)常勤監査役 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000HayashiNorieMember | Original text (Japanese)林 則栄 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000HayashiNorieMember | 1957-05-22 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |